BNB PLUS CORP.

Applied DNA Sciences, Inc. specializes in the manufacturing of biological products for defense and national security applications, leveraging advanced molecular diagnostics and synthetic biology platforms to develop scalable, sequence-verified biotherapeutics and countermeasures. Their technical expertise centers on DNA-based manufacturing processes, including plasmid design, microbial fermentation, and closed-system bioprocessing, with a focus on rapid-response production of novel biological agents under stringent quality control standards. The company’s key differentiator lies in its proprietary DNA synthesis and authentication technologies, enabling traceable, tamper-resistant biological product development critical for military and biomedical readiness programs. The contractor maintains a consistent and focused relationship with the Department of Defense, delivering mission-critical biological manufacturing services that support defense medical readiness, infectious disease countermeasures, and biocontainment initiatives. Work performed aligns with DoD’s biodefense and medical countermeasure priorities, often involving classified or sensitive biological platforms requiring secure, compliant production environments. Their primary industry focus is biological product manufacturing (NAICS 325414), where they operate at the intersection of biotechnology and defense logistics, producing non-diagnostic biological agents such as vaccines, therapeutics, and research reagents under GMP-like conditions. This positions them as a specialized supplier within the national security biomanufacturing ecosystem, serving high-assurance government requirements rather than commercial markets. As a small business structured as a 2L entity based in Stony Brook, New York, Applied DNA Sciences, Inc. operates with a lean, technically focused team. While no formal government certifications are listed, their consistent award history with DoD indicates established compliance with federal biomanufacturing regulations, including FDA and DOD biosecurity protocols. Their geographic presence in a major biotech corridor enhances access to academic and defense research partnerships.